Key result
Medication-by-person interactions explain ~23% of NAR-M adherence variance in patients with multimorbidity.
RCT (n=84)
Randomly assigned subsample
p-value: p=<.10
Adherence to multiple medications varies significantly within individuals across different medications, highlighting the need for medication-specific adherence tracking in multimorbid patients.
Suggests medication-specific adherence monitoring in multimorbidity; leaves open whether targeted interventions improve outcomes.
OBJECTIVE: Chronic conditions often require multiple medication intake. However, past research has focused on assessing overall adherence or adherence to a single index medication only. This study explored adherence measures for multiple medication intake, and in daily life, among patients with multiple chronic conditions (i.e. multimorbidity). DESIGN: Eighty-four patients with multimorbidity and multiple-medication regimens completed three monthly panel questionnaires. A randomly assigned subsample additionally completed a 30-day daily diary. MAIN OUTCOME MEASURE: The Non-Adherence Report; a brief self-report measure of adherence to each prescribed medication (NAR-M), and in daily life. We further assessed the Medication Adherence Report Scale (MARS), and a subsample of participants were randomised to electronic adherence monitoring. RESULTS: = .46, p < .10). Variance components analysis indicated that between-person differences accounted for 10.2% of the variance in NAR-M adherence rates, whereas 22.9% were attributable to medication by person interactions. CONCLUSION: This study highlights the importance and feasibility of studying adherence to multiple medications differentially, and in daily life. Future studies may use these measures to investigate within-person and between-medication differences in adherence.
No takes yet. Share an insight, caveat, or question.
Inauen et al. (2017) conducted an RCT in Multimorbidity (n=84). 30-day daily diary and electronic adherence monitoring vs. Standard panel questionnaires was evaluated on Variance in NAR-M adherence rates (p=<.10). In patients with multimorbidity, between-person differences accounted for 10.2% of the variance in NAR-M adherence rates, while 22.9% was attributable to medication by person interactions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: